title: Impact on diabetes mellitus on the epicardial coronary flow velocity assessed by the thrombolysis in myocardial infarction frame count.
abstract: The aim of this study is to evaluate the effect of type 2 diabetes mellitus on epicardial coronary flow velocity assessed by the thrombolysis in myocardial infarction frame count. The thrombolysis in myocardial infarction frame count was measured in 272 coronary arteries from 101 patients with type 2 diabetes mellitus and in 271 coronary arteries from 104 age- and gender-matched patients without type 2 diabetes mellitus referred for coronary angiography. The thrombolysis in myocardial infarction frame count was measured only in normal arteries or in arteries without significant lesion. By both univariate and multivariate analysis, the thrombolysis in myocardial infarction frame count was not related with either type 2 diabetes mellitus or the duration and glycated hemoglobin levels in the patients with type 2 diabetes mellitus. The thrombolysis in myocardial infarction frame count was significantly associated with body surface area, heart rate, and proximal coronary artery diameter. Type 2 diabetes mellitus did not affect epicardial coronary flow velocity assessed by the thrombolysis in myocardial infarction frame count.
authors.affiliation: Department of Cardiology, Meram Medical School of Selcuk University, 42080, Meram, Konya, Turkey. asoylu44@gmail.com
authors.forename: Ahmet
authors.initials: A
authors.lastname: Soylu
authors.forename: Kurtulus
authors.initials: K
authors.lastname: Ozdemir
authors.forename: Mehmet Akif
authors.initials: MA
authors.lastname: Duzenli
authors.forename: Mehmet
authors.initials: M
authors.lastname: Yazici
authors.forename: Mehmet
authors.initials: M
authors.lastname: Tokac
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D001783:Blood Flow Velocity; D001830:Body Surface Area; D016022:Case-Control Studies; D002932:Cineangiography; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D003326:Coronary Circulation; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006339:Heart Rate; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D015588:Observer Variation; D010496:Pericardium / Q000000981:diagnostic imaging / Q000503:physiopathology*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human